Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
RoActemra 162mg/0.9ml inj pre-filled syringes
1001030W0BBADAD
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
RoActemra 162mg/0.9ml solution for injection pre-filled pens
1001030W0BBAEAE
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
RoActemra 200mg/10ml concentrate for inf vials
1001030W0BBABAB
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
RoActemra 400mg/20ml concentrate for inf vials
1001030W0BBACAC
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
RoActemra 80mg/4ml concentrate for inf vials
1001030W0BBAAAA
|
Roactemra | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.